PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2111542
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 2111542
Hip Replacement Implants Market size was valued at US$ 8,199.7 Million in 2025, expanding at a CAGR of 5.8% from 2026 to 2033.
Hip replacement is said to be one of the procedures in which there is a replacement of the hip joint, which may have become injured or damaged, using an artificial hip implant. This takes place in situations where there is limitation in mobility and presence of pain even as the patient lies at rest. Hip replacement may also be used in order to correct cases of arthritis and injuries to the hips, making movement painful and hard, especially as the patient lies at rest. Hip replacement implants consist of plastics, metals, and ceramics. This allows for easy rotation of the legs. Hip replacement implants are surgical devices that facilitate the treatment of arthritis and injuries to the hips so that they regain their mobility.
Hip Replacement Implants Market- Market Dynamics
Rising Incidence of Diseases to Boost Market Expansion
With the rise in the prevalence of diseases, particularly osteoarthritis and hip-related conditions, there is the rising need for hip replacement implants as organizations in the healthcare industry focus on increasing mobility, reducing pain, and improving the quality of life through orthopedic devices. For instance, in November 2025, according to the OECD Health at a Glance 2025: Japan report, as the incidence of diseases and risk factors continues to rise, burdening the healthcare system further, it is expected to increase the global demand for advanced hip implant devices for the following trends 51% of adults in Japan had insufficient physical activities compared to the OECD average of 30%. In addition, according to the report, 15.7% of the adult population in Japan are daily smokers, and 13.5% report their health as poor or very poor despite having a high life expectancy in the country. These trends are expected to fuel the demand for advanced hip replacement implants globally.
The Global Hip Replacement Implants market is segmented on the basis of Product Type, Fixation, Material, End User, and Region.
Cemented implants hold a notable share due to their popularity amongst the old people with low bone mass density and instant fixation, stability, and good clinical outcomes. In October 2025, Zimmer Biomet stated that the FDA awarded Breakthrough Device Designation for the new total hip replacement system of the company, which is the world's first total hip replacement system treated with iodine to minimize infection risks associated with hip arthroplasty procedures using the iTaperloc(R) Complete and iG7(TM) Hip System. The iTaperloc(R) Complete Hip System is intended not only for cemented but also for cementless total hip replacement surgeries. The company remains the leader in the cemented hip replacement implants industry.
Total Hip Replacement Implants are one of the most common product types used because of their clinical performance, effectiveness in restoring joint functionality, longevity, and increasing use in the treatment of end-stage hip osteoarthritis and degenerative joint diseases. In March 2025, Johnson & Johnson MedTech (DePuy Synthes) presented its new joint reconstruction technologies as advanced total hip replacement implants and digital orthopedic solutions at the AAOS 2025 Annual Meeting, adding value to its hip replacement product portfolio that will help promote total hip replacement implants. These advancements are expected to strengthen the adoption of total hip replacement implants globally.
Hip Replacement Implants Market- Geographical Insights
North America holds a significant position in the Hip Replacement Implants market, as there is a huge prevalence of osteoarthritis along with the growing incidence of hip replacement procedures in the region. For instance, Franciscan Health Org stated that there would be more than 500,000 hip replacements every year in the United States by February 2025 due to population aging. There are other forecasts about the rising number of hip replacement procedures in the US. The number of total hip arthroplasties for patients between the age of 18 and 55 years is projected to increase by 177%, making North America dominant in the Hip Replacement Implants market. This trend is expected to strengthen North America's dominance in the Hip Replacement Implants market.
The competitive landscape for the global Hip Replacement Implants market is intensely rivalrous on account of dynamic product innovation and growth strategies. Major companies like Corin Group, MicroPort Scientific Corporation, Enovis Corporation (DJO), B. Braun Melsungen AG, Medacta International SA, and a number of others have been actively working toward establishing themselves through innovations, partnerships, acquisitions, and expansions considering geographical parameters. In June 2025, Corin Group launched a new innovation in the form of ApolloHipX that represents a highly innovative THA system that includes 3D planning prior to surgery along with intra-operative fluoroscopy. Hence, market competition is expected to intensify with ongoing technological advancements and strategic growth initiatives.
In June 2026, the company DePuy Synthes introduced the technology called VELYS(TM) Hip Navigation with AI Assistance, which is an artificial intelligence-based device used during hip joint replacements. The technology was designed to be used for analysis and identification of structures in images, making the operation process more consistent due to automation of procedures.